baber/WOPTO huggingface dataset:
Patent DE-69817403-T2 (DE)
Inventor: PERSSON LEIF
IPC: C23F13/16
Filed: 1998-12-08
Granted: 2004-07-01
Abstract: A device for treating water that circulates in a closed conduit system, said device comprising a combination of a degasifier, on the one hand, and a corrosion inhibitor, on the other hand. The degasifier includes a tubular member (10) which is horizontal in its use position and which is intended to be connected in series with a conduit (13, 14) forming part of the conduit system. The tubular member is surrounded between its upstream and downstream ends (11, 12) by a housing (17) which includes an openable upper gas outlet (16). The tubular member communicates with the surrounding housing space through the medium of at least one aperture (15) provided therein. The corrosion inhibitor includes a sacrificial anode (20) which is positioned in the housing space outside the tubular member (10). The housing (17) also includes an openable bottom drain or outlet (28).
Patent DE-69825382-T2 (DE)
Inventor: FOUACHE CATHERINE
IPC: A23L27/30
Filed: 1998-09-23
Granted: 2005-08-04
Abstract: Syrups rich in maltose are prepared from liquefied starches by saccharification with a maltogenic  alpha -amylase followed by further saccharification in the presence of a  beta -amylase and a debranching enzyme. Syrups rich in maltose are prepared by successive stages of: (i) liquefaction of a starch suspension; (ii) effecting saccharification of the liquefied starch in the presence of a maltogenic  alpha -amylase; and (iii) continuing the saccharification of the liquefied starch in the presence of at least one  beta -amylase and at least one debranching enzyme selected from pullulanases and isoamylases. Independent claims are also included for the following: (1) a process for producing maltose rich syrups by effecting saccharification of the liquefied starch in a single stage in the presence of a maltogenic  alpha -amylase and at least one debranching enzyme selected from pullulanases and isoamylases; (2) a process comprising subjecting the maltose syrup to a supplementary stage of conversion of the glucose; and (3) a process for producing a syrup rich in maltitol by hydrogenation of the maltose syrup.
Patent DE-69829494-T2 (DE)
Inventor: BERRY JOEL L
IPC: A61M25/09
Filed: 1998-09-10
Granted: 2006-05-24
Abstract: An expandable, intraluminal tubular stent is provided for insertion and expansion within the lumen of a vessel. The stent includes a plurality of longitudinal struts. A series of arcuate or V-shaped end links are connected between the ends of the longitudinal struts. A series of deformable cross-links are circumferentially connected between adjacent longitudinal struts at a center portion of the longitudinal struts to permit the stent to be expanded from a first smaller diameter into a second larger diameter upon insertion into the vessel.
Patent DE-69830317-T2 (DE)
Inventor: DANIELL HENRY
IPC: C12N5/10
Filed: 1998-08-05
Granted: 2006-02-02
Abstract: The invention provides universal chloroplast integration and expression vectors which are competent to stably transform and integrate genes of interest into chloroplast genome of multiple species of plants. Transformed plants and their progeny are provided. Monocotyledonous and dicotyledonous plants are transformed which have never been transformed heretofore. Plants transformed with a synthetic gene express valuable biodegradable protein-based polymers (PBPs). Transformed plants produce high value molecules. Resistance is provided to agricultural crops against the major classes of chemical herbicides. Herbicide resistance is used as a lethal selectable marker for chloroplast transformation. The transformed plants are capable of expressing in addition to the targeted trait, a desirable, secondary non-targeted trait. Insect resistance is provided to transformed plants, both against insects that are susceptible to Bt toxins and against insects that have developed resistance to Bt toxins.
Patent DE-69901838-T2 (DE)
Inventor: GRINVALD AMIRAM
IPC: G06T1/00
Filed: 1999-07-29
Granted: 2003-01-30
Abstract: The invention provides a system for imaging reflectance changes, intrinsic or extrinsic fluorescence changes of a retina (6) due to retinal function, including an imaging illuminator (14) for illumination of the retina (6); a retina-stimulating illuminator (2) for inducing a functional response; an imaging device (20) receiving light from the retina (6) via retinal imaging optics (12); image acquisition means (26) for digitizing and storing images received from the imaging device (20), and a computer (28) for controlling the operation of the system and for processing the stored images to reveal a differential functional signal corresponding to the retina's function.
Patent DE-69904573-T2 (DE)
Inventor: KMACK C
IPC: G06F17/40
Filed: 1999-03-11
Granted: 2003-07-10
Abstract: Systems, methods and computer program products are configured for conducting time and motion studies using a portable computing device having a memory, wherein the internal clock of the portable computing device measures the elapsed time for an observed activity as a user (i.e., time and motion study analyst) identifies the observed activity and any associated parameters, counts, measurements or comments via one or more customized user interfaces displayed on the portable computing device screen. The customized user interfaces are generated from data tables created during setup. The elapsed time, activity name, and the associated parameters, counts and comments are recorded in the memory of the portable computing device as an activity record for subsequent analysis.
Patent DE-69905016-T2 (DE)
Inventor: COSZACH PHILIPPE
IPC: C07D319/12
Filed: 1999-02-24
Granted: 2003-10-09
Abstract: The invention concerns a method for producing dimeric cyclic esters starting with a raw esterification material obtained either from mixing lactic and/or glycolic acid with one of its esters or by extraction at a predetermined time of the esterification process. Said method comprises mild and selective dimerization of the ester, followed by mild and selective cyclization of the dimerised ester and finally purification of the resulting raw material.
Patent DE-69906379-T2 (DE)
Inventor: LANG JACK ARNOLD
IPC: H04N7/16
Filed: 1999-12-23
Granted: 2003-10-23
Abstract: A system, and a corresponding method, for providing a home entertainment device with a modified programme channel. The modified programme channel comprises a schedule of programmes on a programme channel, having modified programme breaks within and/or between the programmes. The system comprises: a programme reception device to receive the programmes on the programme channel; a source of supplementary programme material; output means, coupled to the programme reception device and to the source of supplementary programme material, to output the scheduled programmes and supplementary programme material to the home entertainment device; programme break detection means (such as a clock and/or event handler), coupled to the programme reception device, to detect a break or interruption in a programme; and switching means, responsive to the programme break detection means to switch the output from the programme to the supplementary programme material. Preferably the home entertainment device is a television.
Patent DE-69917331-T2 (DE)
Inventor: KUMPULA MIKKO
IPC: C22C38/52
Filed: 1999-11-15
Granted: 2004-09-23
Abstract: A maraging steel for use as a mold steel is disclosed. In general, the use of maraging steels in molds is limited by the fact that the martensitic microstructure is not stable at temperatures above 480° C. The precipitate hardening maraging type steel according to the invention contains titanium, molybdenum, cobalt, chromium and nickel and has, in addition to high strength, good ductility, small thermal expansion coefficient and good thermal conductivity, a significantly better thermal stability than other maraging steels, which makes it suitable for use as a mold material particularly in pressure casting.
Patent DE-69926900-T2 (DE)
Inventor: MALAVE J
IPC: G16H20/17
Filed: 1999-09-30
Granted: 2006-06-29
Abstract: A communication station is for use with a medical device (such as an infusion pump) and a processing device (such as a computer). The communication station includes a housing, a medical device interface coupled to the housing, a processing device interface coupled to the housing and a processor coupled to the housing. The device interface interfaces with the medical device, and the processing device interface interfaces with the processing device. The processor provides a communication path between the medical device and the processing device such that programming and instructions may be communicated from the processing device to the medical device and data may be transferred from the medical device to the processing device. The communication station may be combined with a system that is capable of generating reports either locally or remotely. In addition, the medical device interface may be a cradle that is configurable to attach to different shaped medical devices.
Patent DE-69931213-T2 (DE)
Inventor: TROMBINI FERRUCCIO
IPC: F16D65/12
Filed: 1999-03-13
Granted: 2006-09-21
Abstract: A brake-disk (10) for railway trains obtained from steel by hot-forming and subsequent roughing-out and finishing mechanical workings, which comprises a crown (12), a hub (14) with a transversally extended through-hole (16) and a connecting intermediate sector (18) which defines, between said crown (12) and said hub (14), an annular chamber (24) open on one side. <IMAGE>
Patent DE-69934687-T2 (DE)
Inventor: CHARASH DAN
IPC: A61B5/04
Filed: 1999-05-28
Granted: 2007-10-18
Abstract: The fundamental frequency of EIG events is determined directly, without first detecting the events themselves. Use is made of an analysis window containing more than one event (3-5). Techniques (1-8) are utilized which are somewhat similar to those utilized to detect, and estimate pitch in speech processing. The invention is based on two important biological discoveries. The first is that the EIG is generated by a functional pace maker. The second is that the EIG signal is quasi-periodic most of the time. The use of pitch detection algorithms is based on the essentially quasi-periodic nature of the EIG signal. Quasi-periodic means that the intervals between successive events are not exactly identical, but may vary slightly, that the amplitude and shape of successive events may also exhibit some variance.
Patent DE-69934706-T2 (DE)
Inventor: BUTLER K
IPC: H04B1/7115
Filed: 1999-10-12
Granted: 2007-10-18
Abstract: A novel and improved method for performing paging is described. In one embodiment of the invention a searcher is used to detect spread spectrum signals. Samples received RF signals are stored in a sample buffer. During standby mode, the samples are gathered during paging slots assigned to the mobile. A set of searches are performed on the samples, and if pilot signals are detected additional demodulation is performed to detect paging messages. The resulting set of demodulation data may be combined to increase detection. After a page message has been detected, additional demodulation resources may be activated to processes more complete page messages, or other information channels. In one embodiment of the invention, the searcher includes a demodulator to perform quick page detection without the use of finger elements to reduce idle mode power consumption.
Patent DE-69935716-T2 (DE)
Inventor: WANG LIXIAO
IPC: A61F2/00
Filed: 1999-04-28
Granted: 2007-08-16
Abstract: A stent having at least one smooth end is disclosed. The stent may include a coating or coatings on one or both end portions to provide a smooth finish to reduce possible damage to body passages when the stent is deployed and delivered. The stent may also contain drugs or surgical adhesives or a combination thereof in or on the coated portion of the stent. The stent may also be of the type where the materials of the stent may be treated to have a smooth flexible end or ends. The stent may also be of a configuration such that at least one end is more flexible than the middle portion of the stent.
Patent HU-E028849-T2 (HU)
Title: Electromagnetic flow meter
Inventor: WRAY TROY
IPC: G01F1/60
Filed: 2004-04-01
Abstract: A method of obtaining a measure of flow from an electromagnetic flow meter (3) having at least one field generating coil and potential sensing electrodes. A composite excitation waveform (1) is applied to the field-generating coil. The waveform comprises at least two frequency components and a plurality of frequency components are simultaneously present for at least a portion of the waveform. The potential sensed by the potential sensing electrodes is sampled to produce a sampled output (5) and the sampled output is correlated (6) with a composite waveform based on the composite excitation waveform. The result of the correlating is used to derive a measure of flow. A measure of trend may be established in the measurements.
Patent HU-E029994-T2 (HU)
Title: Lipid-based compositions of antiinfectives for treating pulmonary infections
Inventor: NICHOLSON SUSAN
IPC: A61K45/06
Filed: 2006-12-05
Abstract: A system for treating or providing prophylaxus against a pulmonary infection is disclosed comprising: a) a pharmaceutical formulation comprising a mixture of free antiinfective and antiinfective encapsulated in a lipid-based composition, and b) an inhalation delivery device. A method for providing prophylaxis against a pulmonary infection in a patient and a method of reducing the loss of antiinfective encapsulated in a lipid-based composition upon nebulization comprising administering an aerosolized pharmaceutical formulation comprising a mixture of free antiinfective and antiinfective encapsulated in a lipid-based composition is also disclosed.
Patent HU-E028137-T2 (HU)
Title: Formulations which stabilize and inhibit precipitation of immunogenic compositions
Inventor: KHANDKE LAKSHMI
IPC: A61K39/00
Filed: 2007-04-19
Abstract: The present invention addresses an ongoing need in the art to improve the stability of immunogenic compositions such as polysaccharide-protein conjugates and protein immunogens. The invention broadly relates to novel formulations which stabilize and inhibit precipitation of immunogenic compositions. More particularly, the invention described hereinafter, addresses a need in the art for formulations which stabilize and inhibit particulate formation (e.g., aggregation, precipitation) of immunogenic compositions which are processed, developed, formulated, manufactured and/or stored in container means such as fermentors, bioreactors, vials, flasks, bags, syringes, rubber stoppers, tubing and the like.
Patent HU-E031630-T2 (HU)
Title: Stabilized tnfr-fc composition comprising arginine
Inventor: GOMBOTZ WAYNE R
IPC: A61K39/38
Filed: 2003-02-27
Abstract: The present invention relates to an aqueous pharmaceutical composition suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin, methods of manufacture, methods of administration and kits containing same.
Patent TR-200001239-T2 (TR)
Title: Tiyazolidinediyon türevlerini hazırlama prosesi.
Inventor: GILES ROBERT GORDON
IPC: C07D417/06
Filed: 1998-10-27
Abstract: A 'in ikameli veya ikamesiz aromatik heteroksiklik grubu; R 'in hidrojen atomu, alkil, asil grubu, aril parçasi ikameli veya ikamesiz aralkil grubu, veya ikameli/ikamesiz bir aril grubu; A 'nin toplam en çok bes ikameli bir benzene halkasi; n'nin 2-6 arasinda bir tamsayi oldugu ve A , R , A  ve n'nin formül (I)'deki gibi olup indirgeme tepkimesinin en az 20 psi hidrojen basinciyla yapilmasiyla karakterize edilen, sonra gerekirse formül (I) bilesiminin bir farmasötik olarak kabul edilebilir tuzunun veya farmasötik olarak kabul edilebilir solvatinin olusturulmasini içeren formül (II)'nin bir bilesiminin katalitik indirgenmesini içeren, bir formül (I) bilesimini, veya bir tautomerik formunu veya farmasötik olarak kabul edilebilir bir tuzunu veya farmasötik olarak kabul edilebilir solvatini hazirlama prosesi.
Patent TR-200100938-T2 (TR)
Title: Köpüklendirme sistemi ve aynısını ihtiva eden deterjan terkipleri
Inventor: KATSUDA RINKO
IPC: C11D3/10
Filed: 1998-10-05
Abstract: Deterjan terkipleri içinde kullanima yönelik olarak özellikle uyarlanmis olan bir kontrollü köpüklendirme sistemi olup, çalkalama olmaksizin köpüklendirme ya da sabun köpügü temin etmenin yeterliligindeki bir köpüklendirme terkip  unsuru, ve bir gecikmeli-salivermeli köpük bastirma terkip unsuru ihtiva etmektedir. Tercihan, gecikmeli-salivermeli köpük bastirma terkip unsuru, böylelikle köpük bastirma amilinin saliverilmesini geciktirmekte olan, bir tasiyicininin içine saliverilebilir olarak birlestirilmektedir. Ayni zamanda, kontrollü köpüklendirme sistemini ihtiva etmekte olan deterjan terkipleri de açiklanmaktadir.
Patent TR-200101570-T2 (TR)
Inventor: KAISER MARIO
IPC: A47B88/04
Filed: 1999-12-10
Abstract: A refrigerating unit includes a cooling chamber, a storage compartment removably guided within the chamber as far as a closing position, and a disengagement device. The chamber has a parallel-guide disposed on its sides. The guide has a mating toothed configuration, two rollers rigidly coupled, lying opposite each other, and each having an external toothed configuration with a pitch circle diameter to be rollingly coupled to the mating toothed configuration. The guide has an end section reached by the rollers near the closing position. One of the mating toothed configuration and the rollers is positionally fixed. The disengagement device disengages the mating toothed configuration from the external toothed configuration of the rollers and is at the end section and has a disengagement length compensating for oblique positioning of the compartment in and counter to a movement direction arising from an offset of the rollers along the mating toothed configuration.
Patent TR-200101979-T2 (TR)
Title: Antidepresyon tedavisi için 5HT1 antagonistleri.
Inventor: BRIGHT GENE MICHAEL
IPC: C07D471/04
Filed: 1999-11-03
Abstract: Mevcut bulus formül (I)'in bilesikleri ile ilgilidir, burada R , R , R  ve R4 tarifname içerisinde açiklanmaktadirlar. Bu bilesikler pisikoterapetik ajanlar olarak yararlidirlar. (FORMÜL VAR)
Patent TR-200102777-T2 (TR)
Inventor: KOCH ERNST-CHRISTIAN
IPC: C06D3/00
Filed: 2000-01-24
Abstract: The invention relates to a pyrotechnic active mass which is impenetrable in the visible spectrum, highly emissive in the infrared spectrum and used for camouflage and decoy purposes. As principal ingredients said mass contains red phosphorus and an alkali metal nitrate or mixture of alkali metal nitrates and as secondary ingredients at least one transition metal or a metal-rich compound or alloy thereof, at least one metalloid and a binder.
Patent DE-602005000154-T2 (DE)
Inventor: MARCHE HERVE
IPC: B64D27/26
Filed: 2005-03-02
Granted: 2007-10-25
Abstract: The system has an additional unit (23) comprising a connecting rod (32) that is integrated to a rigid structure (4) of an attachment strut (6) on one side and to a fan casing (26) of an aircraft engine on another side. The connecting rod is situated in a vertically imaginary plane and oriented according to a longitudinal direction, where the rod is not integrated during en-route phase of the engine. An independent claim is also included for an attachment strut of an aircraft engine including an assembly system.
Patent DE-602005001647-T2 (DE)
Inventor: SIMON BACARDIT JUAN
IPC: B25B27/28
Filed: 2005-04-01
Granted: 2008-04-10
Abstract: The device has an extensible grab (101), whose front end (102) is integrated to a rear end (14) of a bellows. A bellows support (107) has a housing (108) in which the bellows is mounted and a housing (109) in which the grab is mounted. An introduction cone (104) mounted on a free end of a control rod (12). A conical end (106) of the cone traverses the bellows from its front end (15) to its rear end. An independent claim is also included for a process for assembling a bellows on the duct of a pneumatic actuator.
Patent DE-602005001936-T2 (DE)
Inventor: SAN MIGUEL ARRANZ FERNANDO
IPC: E04B2/76
Filed: 2005-05-25
Granted: 2008-05-29
Abstract: Procedure for construction of partitions with siding boards that comprises a profile that rests on the frame on which vertical profiles (3) are set from the floor to the ceiling. Between these posts is set another profile (2) raised from the floor. All ducts for the various installations are laid out on the floor and jut out of the bottom part of the raised profile (2). They are finally covered with mortar or concrete. In this way the mounting of the partions and the installations is simplified, so that in both cases the reduction in labour costs is considerable.
Patent DE-602005004388-T2 (DE)
Inventor: LEE SANG HO
IPC: A46B7/04
Filed: 2005-03-21
Granted: 2009-01-08
Abstract: The object of this invention is to provide a toothbrush which has a structure such that deformed bristles may easily be replaced with new ones. The toothbrush includes a handle having a predetermined length to allow a user to hold the toothbrush, with an insert hole formed in an end of the handle. The toothbrush further includes a bristle support head, with a protrusion provided on the bristle support head, and a plurality of front bristles made of hard material set in the bristle support head. The toothbrush further includes a removable bristle support unit which is provided in the bristle support head, with a plurality of rear bristles made of soft material set in the removable bristle support unit.
Patent DE-69007369-T3 (DE)
Inventor: FURTAK HANS
IPC: C03C3/089
Filed: 1990-08-01
Granted: 1999-07-22
Abstract: Glass compositions useful for forming fibers which are readily able to be degraded in a physiological medium such as that found in a human body. Advantageous compositions formed according to the present invention comprise the following components, set forth in percent by weight: SiO2: 57 to 70% Al2O3: 0 to 5% CaO: 5 to 10% MgO: 0 to 5% Na2O+K2O: 13 to 18% B2O3: 2 to 12% F: 0 to 1.5% P2O5: 0 to 4% Impurities: less than 2%
Patent DE-69013342-T3 (DE)
Inventor: HEADON DENIS
IPC: C12N5/06
Filed: 1990-04-27
Granted: 2005-02-17
Abstract: The verified cDNA sequences for human, bovine and porcine lactoferrin protein have been used to prepare recombinant lactoferrin for therapeutic and nutritional applications. Regions of the cDNA such as the Fe binding sites can be used to make an hLF polypeptide product The present invention provides novel plasmids, transfected eucaryotic cells and methods of producing these plasmids and transfected eucaryotic cells. The novel plasmid contains the cDNA for lactoferrin protein. Methods for the production of lactoferrin protein in fungi and bacteria are also provided. Thus, the present invention provides an efficient and economical means for the production of recombinant lactoferrin protein and lactoferrin related polypeptides.